semaglutide and macular degeneration linked to higher risk of vision problems, FDA data analysis shows Semaglutide Linked to Age-Related Macular

L- 2-3 , -6

Heald AH, Sharma R, Anderson SG, Vyas A, Siddals K, Patel J, Bhatnagar D, Prabharkaran D, Rudenski A, Hughes E, Durrington P, Gibson JM, Cruickshank JK

Discussion This narrative review synthesizes contemporary evidence comparing tirzepatide with semaglutide across glycemic, weight-related, and cardiometabolic domains

Both are commonly used alongside transplants

doi:10.1007/s00394-019-02014-4 Hosoe K, Kitano M, Kishida H, Kubo H, Fujii K, Kitahara M

Furthermore, the amylin receptor agonist, developed by Shionogi and Verdiva Bio, has garnered attention for its oral and subcutaneous formulations, and the two companies have formed a collaboration to develop and promote it worldwide